What is the price target for CLBT stock?
13 analysts have analysed CLBT and the average price target is 22.44 USD. This implies a price increase of 51.21% is expected in the next year compared to the current price of 14.84.
NASDAQ:CLBT • IL0011794802
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLEBRITE DI LTD (CLBT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-12 | Needham | Maintains | Buy -> Buy |
| 2025-11-13 | Lake Street | Maintains | Buy -> Buy |
| 2025-11-13 | Needham | Maintains | Buy -> Buy |
| 2025-11-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-13 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-15 | Lake Street | Maintains | Buy -> Buy |
| 2025-08-14 | Needham | Maintains | Buy -> Buy |
| 2025-06-06 | Needham | Reiterate | Buy -> Buy |
| 2025-05-14 | Needham | Maintains | Buy -> Buy |
| 2025-05-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-02 | Needham | Reiterate | Buy -> Buy |
| 2025-03-27 | Needham | Reiterate | Buy -> Buy |
| 2025-03-10 | Needham | Reiterate | Buy -> Buy |
| 2025-02-14 | Lake Street | Maintains | Buy -> Buy |
| 2025-02-14 | Needham | Reiterate | Buy -> Buy |
| 2025-02-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-22 | Needham | Maintains | Buy -> Buy |
| 2024-12-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-07 | Needham | Maintains | Buy -> Buy |
| 2024-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-07 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-25 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-23 | TD Cowen | Maintains | Buy -> Buy |
| 2024-08-16 | Lake Street | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 325.11M 20.10% | 401.203M 23.41% | 475.675M 18.56% | 577.73M 21.45% | 678.68M 17.47% | 787.41M 16.02% | 880.67M 11.84% | |
| EBITDA YoY % growth | 43.248M 324.42% | 67.513M 56.11% | 78.347M 16.05% | 154.81M 97.60% | 188.24M 21.59% | 226.13M 20.13% | 274.99M 21.61% | |
| EBIT YoY % growth | 33.237M 3,223.70% | 56.906M 71.21% | 66.48M 16.82% | 146.32M 120.10% | 179.28M 22.53% | 214.34M 19.56% | 258.88M 20.78% | |
| Operating Margin | 10.22% | 14.18% | 13.98% | 25.33% | 26.42% | 27.22% | 29.40% | |
| EPS YoY % growth | 0.30 204.00% | 0.42 38.16% | 0.50 19.05% | 0.56 11.32% | 0.63 13.84% | 0.79 23.95% | 0.92 16.88% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.10 0.98% | 0.12 1.86% | 0.16 11.11% | 0.16 16.86% | 0.12 20.71% | 0.14 15.16% | 0.19 20.00% | 0.18 10.97% |
| Revenue Q2Q % growth | 129.38M 20.30% | 137.65M 21.52% | 145.82M 15.70% | 152.6M 18.46% | 150.65M 16.44% | 153.2M 11.30% | 164.02M 12.48% | 172.28M 12.90% |
| EBITDA Q2Q % growth | 27.706M 85.96% | 33.637M 71.27% | 40.222M 49.44% | 44.058M 34.85% | 36.21M 30.69% | 40.188M 19.48% | 51.306M 27.56% | 52.122M 18.30% |
| EBIT Q2Q % growth | 25.986M 111.82% | 31.887M 121.18% | 38.037M 100.30% | 41.831M 101.06% | 33.66M 29.53% | 37.638M 18.04% | 48.756M 28.18% | 49.572M 18.51% |
All data in USD
13 analysts have analysed CLBT and the average price target is 22.44 USD. This implies a price increase of 51.21% is expected in the next year compared to the current price of 14.84.
CELLEBRITE DI LTD (CLBT) will report earnings on 2026-05-12.
The consensus EPS estimate for the next earnings of CELLEBRITE DI LTD (CLBT) is 0.1 USD and the consensus revenue estimate is 129.38M USD.
The expected long term growth rate for CELLEBRITE DI LTD (CLBT) is 17.73%.